                         SEQUENCE LISTING

<110>  Del Mar Pharmaceuticals
       Brown, Dennis M.
       Bacha, Jeffrey A.
       Garner, William J.
 
<120>  METHODS FOR TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT 
       MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 
       DYSREGULATIONS OR MUTATIONS EMPLOYING DIANHYDROGALACTITOL, 
       DIACETYLDIANHYDROGALACTITOL, DIBROMODULCITOL, OR ANALOGS OR 
       DERIVATIVES THEREOF

<130>  P6886PC00

<140>  PCT/US13/47320
<141>  2013-06-24

<150>  US 61/824,672
<151>  2013-05-17

<150>  US 61/664,279
<151>  2012-06-24

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  198
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Ala Lys Gln Pro Ser Asp Val Ser Ser Glu Cys Asp Arg Glu Gly 
1               5                   10                  15      


Arg Gln Leu Gln Pro Ala Glu Arg Pro Pro Gln Leu Arg Pro Gly Ala 
            20                  25                  30          


Pro Thr Ser Leu Gln Thr Glu Pro Gln Gly Asn Pro Glu Gly Asn His 
        35                  40                  45              


Gly Gly Glu Gly Asp Ser Cys Pro His Gly Ser Pro Gln Gly Pro Leu 
    50                  55                  60                  


Ala Pro Pro Ala Ser Pro Gly Pro Phe Ala Thr Arg Ser Pro Leu Phe 
65                  70                  75                  80  


Ile Phe Met Arg Arg Ser Ser Leu Leu Ser Arg Ser Ser Ser Gly Tyr 
                85                  90                  95      


Phe Ser Phe Asp Thr Asp Arg Ser Pro Ala Pro Met Ser Cys Asp Lys 
            100                 105                 110         


Ser Thr Gln Thr Pro Ser Pro Pro Cys Gln Ala Phe Asn His Tyr Leu 
        115                 120                 125             


Ser Ala Met Ala Ser Met Arg Gln Ala Glu Pro Ala Asp Met Arg Pro 
    130                 135                 140                 


Glu Ile Trp Ile Ala Gln Glu Leu Arg Arg Ile Gly Asp Glu Phe Asn 
145                 150                 155                 160 


Ala Tyr Tyr Ala Arg Arg Val Phe Leu Asn Asn Tyr Gln Ala Ala Glu 
                165                 170                 175     


Asp His Pro Arg Met Val Ile Leu Arg Leu Leu Arg Tyr Ile Val Arg 
            180                 185                 190         


Leu Val Trp Arg Met His 
        195             


<210>  2
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  2

Ile Ala Gln Glu Leu Arg Arg Ile Gly Asp Glu Phe Asn Ala Tyr 
1               5                   10                  15  


<210>  3
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  3

Leu Ala Cys Ile Gly Asp Glu Met Asp 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  4

Leu Lys Ala Leu Gly Asp Glu Leu Asp 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  5

Leu Ala Ile Ile Gly Asp Asp Ile Asn 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  6

Leu Ala Gln Val Gly Asp Ser Met Asp 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  7

Leu Lys Arg Ile Gly Asp Glu Leu Asp 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  8

Leu Lys Lys Asn Ser Asp Trp Ile Trp 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  9

Leu Arg Arg Met Ser Asp Glu Phe Glu 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  10

Leu Arg Gln Ala Gly Asp Asp Phe Ser 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  11

Leu Arg Glu Ala Gly Asp Glu Phe Glu 
1               5                   


<210>  12
<211>  60
<212>  DNA
<213>  Homo sapiens

<400>  12
gatccccgtg atgatcccga cactatttca agagaatagt gtcgggatca tcacttttta       60


<210>  13
<211>  60
<212>  DNA
<213>  Homo sapiens

<400>  13
agcttaaaaa gtgatgatcc cgacactatt ctcttgaaat agtgtcggga tcatcacggg       60


